Introduction
Clinical trials in patients with cystic fibrosis (CF) have provided proof-of-principle for gene transfer to the airway epithelium; 1,2 however, gene delivery is inefficient. Several studies have shown that extracellular barriers such as mucus and sputum 3, 4 and mucocilary clearance significantly reduce transfection efficiency. To circumvent these topical barriers, we have assessed the feasibility of intravenous (i.v.) delivery of liposomecomplexed and 'naked' oligonucleotides (ODNs) to the airway epithelium.
We assessed delivery of ODNs, rather than plasmid DNA, for several reasons. (1) ODNs are easier to track with fluorescent microscopy because more fluorescent molecules can be injected per mg of DNA. (2) ODNs can be rendered nuclease-resistant by substituting one of the non-binding oxygen atoms in the phosphate backbone for sulphur to form phosphorothioated ODNs, 5 allowing i.v. administration of 'naked' ODNs. This is important because 'naked' ODNs are likely to remain smaller once within the circulation than liposome complexes, and this may increase their chance of escaping from the vasculature. (3) Cytoplasmic delivery of ODNs to the nucleus should be more efficient that plasmid DNA. Several in vitro studies have shown that intracellular transport of DNA is sizedependent and smaller ODNs are able to move more quickly in the cytoplasm. 6, 7 (4) ODNs are relevant to CF in the context of gene repair and downregulation of genes involved in the pathogenesis of lung disease.
The conducting airways are likely to be the most important target for CF gene therapy and are supplied by the bronchial circulation. We, therefore, hypothesized that the epithelium of these airways is more likely to be transfected by ODNs that have escaped from the bronchial, rather than the pulmonary vasculature. ODNs that escape from pulmonary capillaries would need to diffuse through the airway wall to reach the basolateral membrane of the airway epithelial cells. This may be feasible in the smallest bronchioles because the distance separating the target epithelium from the surrounding alveoli is relatively small and the airway wall is composed of only thin muscle and delicate connective tissue layers. However, as the airways become larger, the distance separating the airway epithelial cells and alveoli becomes larger and the airway wall includes components such as cartilage and mucus-secreting glands that may block diffusion. In contrast, the bronchial capillaries lie directly beneath the airway epithelial cell basement membrane and therefore the barriers following extravasation are less formidable.
It is therefore important when assessing ODN transfer to conducting airways to deliver via the appropriate vasculature in animal models. The mouse is often used as a model for i.v. gene transfer, but its lung vasculature is different from that of man. In mice, the bronchial circulation supplies only the trachea, main bronchi and very proximal intrapulmonary airways (IPAs), and the pulmonary circulation supplies the remaining more distal conducting airways. 8, 9 We, therefore, restricted our evaluation of ODN delivery to the mouse trachea and main bronchi, to limit any contribution from the pulmonary circulation.
Intravenously injected gene transfer agents have to pass through the pulmonary circulation to reach the bronchial circulation. Liposome-protamine-DNA (LPD) complexes, administered by this route, have been shown to transfect several organs distal to the pulmonary circulation, such as the liver and spleen, 10 suggesting that a proportion of these complexes also pass through the bronchial circulation. We, therefore, used LPD complexes in our studies and compared these to 'naked' ODNs.
LPD and 'naked' ODNs are required to escape from the bronchial microvasculature to reach the basolateral membrane of the epithelial cells. The bronchial capillaries in healthy humans are composed of continuous endothelium, the least leaky type of vasculature. In contrast, the bronchial circulation of rats, guinea-pigs and hamsters is composed of the more leaky fenestrated endothelium. 11, 12 However, only a few fenestrations have been reported in the vessels supplying the mouse trachea. 13 We hypothesized that inflammatory mediators might increase the escape of these agents from the circulation. Inflammatory mediators are released by the airway wall and are thought to induce plasma leakage from the bronchial vasculature by causing the formation of gaps between the endothelial cells of post-capillary venules.
14-17 Inflammatory mediators have previously been shown to cause the formation of gaps up to 500 nm between bronchial endothelial cells in rat and dog airways. 18, 19 Previous studies have shown that inflammatory mediators increase the delivery of gene transfer agents to other tissues. [20] [21] [22] Here, we evaluated the effects of three inflammatory mediators, platelet-activating factor (PAF), histamine and bradykinin and assessed whether the most effective inflammatory mediator(s) could increase escape of LPD and 'naked' ODNs from the bronchial circulation and consequently, increase transfection of the conducting airway epithelium.
Results

I.v. injection of liposome-complexed ODNs does not result in delivery to conducting airway epithelium
We first determined if LPD complexes were able to reach the bronchial circulation and escape from the vasculature after i.v. administration. As expected, large numbers of cells in the lung parenchyma were transfected (Figure 1a  and b) . Importantly, complexes could be detected in the more distal bronchial circulation (Figure 1c and d) , with fluorescent signal detected within the bronchial endothelial cells. However, the majority of the LPD complexes were unable to escape from the bronchial circulation into the interstitium surrounding the airways. LPD complexes were not delivered to the conducting airway epithelium.
Development of a bronchial microvascular leakage model
A model of bronchial microvascular leakage was subsequently developed, using intravenously injected inflammatory mediators, in an attempt to increase LPD escape from the bronchial vasculature. Dose-response curves for PAF, histamine and bradykinin were individually generated to identify the dose that caused the greatest amount of Evans blue (EB) extravasation from the bronchial vasculature.
PAF. Both 10 and 20 mg/kg significantly (Po0.05) increased microvascular leakage in the larynx/trachea (10 mg/kg ¼ 24 mg EB/g tissue, inter-quartile range (IQR) 21-27; 20 mg/kg ¼ 20 mg EB/g tissue, IQR 15-24) when compared to the control (3 mg EB/g tissue, IQR 3-6), and in the main bronchi (10 mg/kg ¼ 49 mg EB/g tissue, IQR 43-60; 20 mg/kg ¼ 55 mg EB/g tissue, IQR 49-58) when compared to the control (27 mg EB/g tissue, IQR 24-37) (n ¼ 6/group). However, leakage was not increased in the IPAs or parenchyma. The higher dose of 40 mg/kg was fatal (n ¼ 4) and therefore was not included in the EB analysis. As there was no difference between the 10 and 20 mg/kg doses, the former was chosen as the most effective dose. All mice survived an i.v. injection of 10 mg/kg (n ¼ 4).
Histamine. Only 150 mg/kg significantly (Po0.05) increased microvascular leakage in the larynx/trachea (29 mg EB/g tissue, IQR 24-33) when compared to the control (14 mg EB/g tissue, IQR 11-18) (n ¼ 6/group). None of the doses tested altered leakage in the main bronchi, IPA or parenchyma. All doses above 350 mg/kg had a survival rate of o50% (n ¼ 4/group) and were not included in the analysis. Only 150 mg/kg increased leakage and was therefore chosen as the most effective dose. [14] [15] [16] [17] [18] [19] [20] . None of the doses tested altered leakage in the parenchyma. Administration of 100 mg/kg resulted in only 25% survival (n ¼ 4), and therefore this dose was not included in the EB analysis; 50 mg/kg did not cause any mortality (n ¼ 5) and was chosen as the most effective dose.
Intravenous delivery of oligonucleotides to conducting airways E Holder et al Combination of mediators. To further increase leakage from the bronchial vasculature, the most effective doses of two mediators were combined. None of the animals that received histamine and bradykinin, or PAF and bradykinin, recovered from anaesthesia and therefore EB extravasation was not analysed. However, as three of the four animals receiving PAF and histamine survived, leak was compared to the most effective doses of the individual mediators. The combined dose of PAF and histamine (at their individual optimal doses) induced significantly (Po0.05) greater microvascular leakage than the most effective dose of either PAF or bradykinin alone in the larynx/trachea (Figure 2a ), than PAF alone in the main bronchi (Figure 2b ) or than PAF alone in the IPAs (Figure 2c ). Similar to the mediators administered individually, the combined administration of PAF and histamine did not increase leakage in the parenchyma. Although statistically, there was no difference between the amount of leakage induced by the combined dose of PAF and histamine compared to histamine alone, graphical analysis (Figure 2a -c) suggested a trend towards more leakage with the combined dose. Given this, the combination of PAF and histamine was used in further studies.
Gross observation of the mouse airways revealed that all mediators induced the same pattern of EB extravasation.
Leakage in the trachea and main bronchi was always clearly visible as dark blue staining (Figure 2d and e). Leakage in the IPAs was apparent only in the very proximal region and not in the distal airways or parenchyma.
An optimal combination of inflammatory mediators does not result in conducting airway epithelial DNA transfer
We next determined if a combination of PAF and histamine would increase LPD escape from the bronchial vasculature. Confocal analysis (Figure 3a ) with subsequent quantification (Figure 3b ) showed that these inflammatory mediators did not significantly increase the amount of LPD complex outside the vessels. Thus, the majority of LPD complexes were not able to escape from bronchial capillaries, and the complexes did not transfect airway epithelial cells.
I.v. injection of 'naked' ODNs can achieve transfection of conducting airway epithelium, predominantly within the cytoplasm 'Naked' ODNs are likely to retain their relatively small size (compared to lipoplexes) when injected into the circulation. We, therefore, assessed whether 'naked' 
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ODNs were able to escape from the bronchial capillaries and transfect airway epithelial cells. We also determined whether increasing bronchial vascular leakage would have an effect on these parameters. Initially, to maintain consistency with the dose administered when using LPD complexes, each animal received 50 mg 'naked' ODN. As predicted, the 'naked' ODNs passed through the pulmonary vasculature and did not transfect the lung parenchyma. Very small amounts of fluorescent signal were seen within the interstitium of the trachea and main bronchi; only nine epithelial cells were transfected in all images analysed from six animals (a total of 4717 cells counted). We then repeated these studies with the optimum dose of PAF and histamine. Under these conditions, gross observation indicated that more ODNs were extravasated from the vasculature; however, only 32 epithelial cells were transfected in all images analysed from six animals (a total of 5425 cells counted) (Figure 4) .
We next determined if increasing the dose by 10-fold (500 mg ODN/animal) would increase ODN delivery to the epithelial cell. At this dose, from gross observation, the ODNs did transfect lung parenchyma but this was less than that observed with 1 log lower concentration of LPD. Additionally, cells likely to be macrophages were seen in the lumen of the airways and contained ODNs. More importantly, large quantities of ODNs escaped from the bronchial vasculature and efficiently transfected the airway epithelium (Figure 5a and b) . The signal in the epithelial cells appeared as punctate spheres, predomi- Intravenous delivery of oligonucleotides to conducting airways E Holder et al nantly in the cytoplasm. A median of 17% (IQR 10-34%) and 35% (IQR 24-59%) of airway epithelial cells were transfected/confocal image, in the absence and presence of the inflammatory mediators, respectively (Po0.05, compared to controls) (Figure 5c ). Inflammatory mediators did not increase the percentage of epithelial cells transfected. We also observed ODN uptake in the liver and in the red pulp in the spleen of animals injected with 500 mg ODN in the absence of inflammatory mediators ( Figure 6 ).
Despite successful cytoplasmic delivery to airway epithelial cells, relatively little ODNs appeared to be nuclear localized. For those cells showing nuclear localization, two very different types of nuclear localized signal were observed; punctate and diffuse. (a) Bright punctate dots of fluorescence were observed in the 4 0 ,6-diamidino-2-phenylindole (DAPI)-stained nuclei as a turquoise colour due to the green fluorescence overlaying the blue nuclei (Figure 7a and b) . This punctate signal was almost always on the inner edge of the nucleus. Quantification showed that a median of 3% (IQR 2-6%) and 6% (IQR 4-7%) airway epithelial cells contained punctate nuclear localized signal in the absence and presence of inflammatory mediators, respectively ( Figure  7c ). Both groups (with and without the inflammatory mediators) were significantly (Po0.05) different from controls, but not significantly different from each other. (b) Airway epithelial cells with a diffuse nuclear localized signal were also observed (Figure 8a and b) . In most cases, the signal was not as bright as the punctate signal and consequently, was concealed by DAPI. This diffuse signal was seen only in very small numbers of cells. Only 30 epithelial cells with diffuse nuclear localized signal were observed in all images quantified from six animals (a total of 4483 cells counted) in the absence of inflammatory mediators, and only 30 epithelial cells in all images quantified (a total of 4907 cells counted) in the presence of inflammatory mediators (Figure 8c) .
The airway distribution of diffuse and punctate nuclear localized signal was quantified in a separate cohort of animals (n ¼ 3). The punctate nuclear localized signal was visible in airway epithelial cells throughout the trachea and main bronchi, and did not appear to be preferentially localized to any particular region of the airways. Conversely, the diffuse signal was predominantly observed in airway epithelial cells located in the more proximal region of the trachea. Using the fourth cartilage plate below the main concentration of sub- Intravenous delivery of oligonucleotides to conducting airways E Holder et al mucosal glands as a divide to separate proximal regions of the trachea from the lower airways, an average of 6% of airway epithelial cells (range ¼ 3-16%) above the fourth cartilage plate contained diffuse nuclear localized signal compared to 0% (range ¼ 0-0.1%) below the fourth cartilage plate.
Discussion
Here, we show that 'naked' ODNs, under certain conditions, are capable of transfecting up to 35% of conducting airway epithelial cells and 6% of nuclei following i.v. administration. LPD complexes were considerably less Intravenous delivery of oligonucleotides to conducting airways E Holder et al efficient, whereas the effect of optimized leakage mediators on either 'naked' or liposome-complexed ODNs was small.
I.v. delivery of LPD
Previous studies have demonstrated that the pulmonary vasculature has the highest transfection after an i.v. injection of LPD. 23 However, some of the complexes were able to pass through the pulmonary circulation and transfect distal organs, 10 suggesting that some LPD may have also reached the bronchial circulation. Similar to previously published studies, we found that LPD transfected the lung parenchyma efficiently. However, only a comparatively small amount of LPD reached and escaped from the bronchial vasculature into the interstitium. Airway epithelial cell transfection did not occur. LPD complexes may have not been able to leave the vasculature because they were too large to pass through the intercellular gaps. Similarly, McLean et al. 24 demonstrated that 1-[2-(9 (Z)-octadecenoyloxy)ethyl]-2-(8 (Z)-heptadecenyl)-3-(2-hydroxyethyl)imidazolinium chloride (DOTIM)-cholesterol/ DNA complexes are not able to escape from the vasculature in the trachea of mice after i.v. administration. In normal circumstances, bronchial vessels are not permeable to carbon particles that are 25-50 nm in diameter. 19 LPD complexes are much larger; complexes containing plasmid DNA increase from 135 nm (742 nm) to 490 nm (7102 nm) after incubation in serum for 30 s. 10 Inflammatory mediators have previously been shown to cause the formation of gaps up to 500 nm between bronchial endothelial cells. 18, 19 We, therefore, developed a model of bronchial microvascular leakage using the inflammatory mediators PAF, histamine and bradykinin, in an attempt to open the gaps between the bronchial endothelial cells and allow more LPD complexes to escape from the bronchial vasculature. Although the combined optimized doses of PAF and histamine significantly increased leakage in the larynx/trachea and main bronchi, the mediators did not increase LPD escape from the bronchial vasculature. This may be because LPD complex size increases with time and becomes larger than the gaps formed by the inflammatory mediators. Interestingly, Koehler et al. 25 have previously shown that intravenously injected DODAC: DOPE cationic liposome/DNA complexes are able to transfect airway epithelial cells in the primary bronchi and submucosal glands of mice. Additionally, Ferkol Intravenous delivery of oligonucleotides to conducting airways E Holder et al et al. 26 have shown that 25 nm poly-L-lysine/DNA complexes targeted to the polymeric immunoglobulin receptor are able to leave the vasculature and transfect airway epithelial cells in the trachea and upper airways of rats. It may be that these complexes remain small enough to escape through the gaps between the bronchial endothelial cells, or are able to escape via a different mechanism, such as through transendothelial channels shown to occur in the bronchial venules of rats, guinea-pigs and hamsters. 12 I.v. delivery of 'naked' ODNs 'Naked' ODNs are likely to remain smaller in the circulation than LPD complexes and were, therefore, evaluated. Initially, we injected 50 mg of 'naked' ODNs per animal; however, airway epithelial cell transfection was extremely rare, even in the presence of inflammatory mediators. Increasing the dose of the 'naked' ODNs by 10-fold resulted in a significant increase in bronchial vascular escape and airway epithelial cell transfection. No fluorescence was detected in any sections from mice that received either 0, 50 or 500 mg of non-phosphorothioated ODNs (n ¼ 3/group) (identical to ODNs described in this study except for a normal sugar-phosphate backbone and are consequently, rapidly degraded in the serum) suggesting that the fluorescent signal observed in this study represents intact ODNs (data not shown). Most ODNs were localized within the cytoplasm, rather than the nucleus of airway epithelial cells. Once in the cytoplasm, the 13.2 kDa ODNs should in theory be able to enter the nucleus because molecules less than 40-60 kDa can passively diffuse through the nuclear pore complex. 27 However, the punctate cytoplasmic distribution suggests that most of the ODNs are contained within vesicles 28, 29 and are not available for nuclear uptake. Nuclear localization was observed in a small number of cells, with two very different patterns. The punctate nuclear localized signal was nearly always observed around the inner nucleus edge, perhaps in a subcellular compartment. Using this technique, we cannot exclude the possibility that the DAPI signal may not accurately define the nuclear edge. In contrast, the diffuse nuclear localized signal evenly covered the nucleus. These cells were located more proximally in the trachea and were often found above, or close to, the submucosal glands. One explanation might be that more ODNs were delivered to the airway epithelial cells in this region. The human vasculature is more leaky around the submucosal glands, 11 and the mouse vasculature may be similar. It is unknown which type of nuclear signal is more biologically relevant, although in vitro studies have shown that a diffuse pattern of nuclear localization results in downregulation of interleukin-8. 30 Similar to previously published studies, we detected ODNs in the red pulp of the spleen, whereas the white pulp was less efficiently transfected. 31 The red pulp is a highly vascular tissue and allows the passage of blood through the parenchyma, where phagocytic cells remove particulate matter and aged/ abnormal red blood cells. Also in concordance with the literature, we observed ODN uptake in the liver, which is expected given the known role of this organ in ODN clearance.
31,32
Therapeutic relevance
ODNs may be therapeutically relevant to CF in three ways. (1) ODNs may be used as decoy molecules to downregulate inflammation. In CF, the imbalance between pro-and anti-inflammatory cytokine production results in chronic inflammation. Nuclear factor (NF)-kB is a transcription factor involved in the regulation of many proinflammatory mediators and NF-kB decoys have been shown to downregulate interleukin-8 secretion in CF epithelial cell lines. 30 We used NF-kB decoys as a prototype to assess i.v. delivery of small DNA molecules to the airway epithelial cells via the bronchial circulation. However, decoy delivery to the nucleus of many epithelial cells is likely necessary for effective anti-inflammatory therapy and therefore, ODN nuclear localization observed in this i.v. study is probably insufficient. (2) ODNs may be used as antisense molecules to downregulate genes such as the epithelial cell sodium channel (ENac) and correct the salt imbalance in the CF lung, although as with decoys, this approach will likely require nuclear localization in many epithelial cells. (3) ODNs may be used as gene correction molecules. Although previous studies have suggested that CFTR expression is needed in only 5% of airway epithelial cells to correct the chloride transport defect, 33 gene correction molecules will probably need to be delivered to the nucleus of many more cells as the process of gene repair is inefficient. Nuclear localization signals have been attached to DNA in an attempt to increase nuclear import. 34, 35 This has been shown to be effective in some cell types, 36, 37 but remains to be evaluated in airway epithelial cells. The results of this study, along with the potential of nuclear localization signals, may increase the possibility of decoy, antisense and gene repair use in CF.
Our work provides the first step towards using small DNA molecules for the therapeutic purposes described above. In conclusion, we have shown that intravenously injected 'naked' ODNs are able to escape from the bronchial circulation and transfect conducting airway epithelial cells, the target cells for CF.
Materials and methods
Gene transfer agents
ODNs: Complementary HPLC-purified NF-kB decoy phosphorothioate ODNs with a 5 0 fluorescein label (Thermo Hybaid, Ashford, UK) were re-suspended in nuclease-free water and annealed over 2 h using a temperature gradient ranging from 80 to 251C, as published previously. 38 Forward sequence: 5 0 -CCT TGA AGG GAT TTC CCT CC-3 0 and reverse sequence: 5 0 -GGA GGG AAA TCC CTT CAA GG-3 0 . These NF-kB decoy ODNs were used as a prototype for small DNA molecules. Nuclease-free water was used as the vehicleonly control. Liposome complexes: The lipid vector consisting of DOTAP/cholesterol liposome and protamine was complexed with the ODNs to produce LPD complexes at ratios previously shown to be optimal for i.v. administration. 10 Lipid alone (DOTAP/cholesterol liposome and protamine) was used as the vehicle-only control.
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Development of bronchial microvascular leakage model
PAF (Sigma-Aldrich Company Ltd, Dorset, UK) was diluted in saline with 1% dimethyl sulphoxide and 0.25% bovine serum albumin. Bradykinin (Sigma-Aldrich Company Ltd) and histamine (Sigma-Aldrich Company Ltd) were diluted in saline. The doses chosen for each mediator (PAF: 0, 10, 20, 40 mg/kg; histamine: 0, 150, 250, 350, 400, 500 mg/kg; bradykinin: 0, 5, 50, 75, 100 mg/kg) were based on previous studies. The most effective dose was defined as the dose that generated the highest amount of EB leakage in the larynx/trachea and main bronchi with a survival rate of 475%.
Balb/C mice (male, 5-8 weeks) were anaesthetized by intraperitoneal injections of Hypnorm/Hypnovel (Janssen Pharmaceutica, Beerse, Belgium and Roche Diagnostics Ltd, Sussex, UK) or Avertin. 39 Animals was injected with 100 ml of EB (6 mg/ml in saline, filtered through a 5 mm filter) (Sigma-Aldrich Company Ltd) into the tail vein. One minute later, 100 ml of inflammatory mediator or diluent (n ¼ 6/group, except n ¼ 3/group for 350 mg/kg of histamine) were injected into the tail vein. Six minutes after the EB injection, the systemic and pulmonary circulations were perfused with saline through the left and right ventricles, respectively, to remove the blood using a 22-gauge Abbocath-T catheter (Southern Syringe, London, UK). The atria were cut to allow the escape of excess liquid. When the fluid leaving the atria was clear, the lungs were removed and dissected into the larynx/trachea, main bronchi, IPAs and parenchyma. The IPAs were separated from the parenchyma by gentle scraping with a razor blade. Tissues were incubated in 100% formamide (BDH, Merck Ltd, Leicestershire, UK) for 24 h at 371C to extract the EB. Tissues were removed, blotted on tissue paper and weighed. The absorbance of the formamide solution was measured at 620 nm and EB concentration determined by comparison with a standard curve.
Gene transfer experiments
Balb/C mice (male, 5-8 weeks) were anaesthetized with intraperitoneal injections of Avertin. 39 LPD (50 mg ODN in 300 ml/animal) or 'naked' ODNs (50 or 500 mg ODN in 100 ml/animal) or appropriate vehicle (see above) was injected via the tail vein (six animals/ group). PAF (10 mg/kg) plus histamine (150 mg/kg) (the optimal leakage mediators and dosage), or vehicle was injected via the tail vein within 1 min later. Twentyfour hours after injection, the lungs were removed and dissected into trachea, main bronchi and individual lung lobes.
This time point was chosen because previously published LPD studies had already evaluated transfection at 24 h after i.v. 10 A pilot study (500 mg/ animal, n ¼ 3) suggested that epithelial cell transfection was not greater at 4 h compared to 24 h (data not shown). The liver and spleen were removed from a cohort of animals injected with 'naked' ODNs (500 mg/animal) followed by an i.v. injection of leakage mediator vehicle (n ¼ 3 mice).
Tissues were fixed in 2% paraformaldehyde (pH 7.3) (BDH, Merck Ltd, Leicestershire, UK) overnight at 41C and processed to paraffin wax. To reduce autofluorescence, the standard formalin processing step was omitted, the stages of alcohol dehydration were reduced to 5 Â 30 min, the chloroform washes reduced to 2 Â 30 min and the wax infiltration stage reduced to 4 Â 30 min. Wax-embedded, 5-mm sections of tissue were cut, counterstained with DAPI (Roche Diagnostics Ltd, Sussex, UK) (1 mg/ml in phosphate-buffered saline for 15 min) to visualize nuclei and mounted with Immunofluore (ICN Pharmaceuticals Ltd, Hampshire, UK). Confocal microscopy was used to visualize the fluorescent ODNs. Confocal images were taken through the Z axis of the cells and each image represents a single 1-mmthick optical section.
Quantifying ODN transfer to the trachea and main bronchi
Six animals/group and 9-11 images/animal were analysed (4-6 images/trachea, 4-6 images/main bronchi). The median value for each animal was calculated and used for statistical analysis. The number of cells with diffuse signal throughout the nucleus was divided by the total number of airway epithelial cells in that image, and then multiplied by 100. DAPI often concealed the diffuse nuclear localized signal. Therefore, quantification was conducted using images without DAPI and then compared to corresponding DAPI images to ensure signal was nuclear localized.
Statistical analysis
The results are expressed as the median and IQR. The Mann-Whitney U-test for unpaired non-parametric data was used to compare data between two or three groups.
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